Keywords
Last Name
Institution

David F. Bishop

TitlePROFESSOR
InstitutionMount Sinai
DepartmentGenetics and Genomic Sciences
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Clavero S, Ahuja Y, Bishop DF, Kwait B, Haskins ME, Giger U, Desnick RJ. Diagnosis of feline acute intermittent porphyria presenting with erythrodontia requires molecular analyses. Vet J. 2013 Dec; 198(3):720-2.
      View in: PubMed
    2. Austin C, Smith TM, Bradman A, Hinde K, Joannes-Boyau R, Bishop D, Hare DJ, Doble P, Eskenazi B, Arora M. Barium distributions in teeth reveal early-life dietary transitions in primates. Nature. 2013 Jun 13; 498(7453):216-9.
      View in: PubMed
    3. Balwani M, Doheny D, Bishop DF, Nazarenko I, Yasuda M, Dailey HA, Anderson KE, Bissell DM, Bloomer J, Bonkovsky HL, Phillips JD, Liu L, Desnick RJ. Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria. Mol Med. 2013; 19:26-35.
      View in: PubMed
    4. Bishop DF, Tchaikovskii V, Nazarenko I, Desnick RJ. Molecular expression and characterization of erythroid-specific 5-aminolevulinate synthase gain-of-function mutations causing X-linked protoporphyria. Mol Med. 2013; 19:18-25.
      View in: PubMed
    5. Bishop DF, Tchaikovskii V, Hoffbrand AV, Fraser ME, Margolis S. X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the ß-subunit of succinyl-CoA synthetase (SUCLA2). J Biol Chem. 2012 Aug 17; 287(34):28943-55.
      View in: PubMed
    6. Camacho-Vanegas O, Camacho SC, Till J, Miranda-Lorenzo I, Terzo E, Ramirez MC, Schramm V, Cordovano G, Watts G, Mehta S, Kimonis V, Hoch B, Philibert KD, Raabe CA, Bishop DF, Glucksman MJ, Martignetti JA. Primate genome gain and loss: a bone dysplasia, muscular dystrophy, and bone cancer syndrome resulting from mutated retroviral-derived MTAP transcripts. Am J Hum Genet. 2012 Apr 6; 90(4):614-27.
      View in: PubMed
    7. Zhang J, Yasuda M, Desnick RJ, Balwani M, Bishop D, Yu C. A LC-MS/MS method for the specific, sensitive, and simultaneous quantification of 5-aminolevulinic acid and porphobilinogen. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Aug 15; 879(24):2389-96.
      View in: PubMed
    8. Bishop DF, Clavero S, Mohandas N, Desnick RJ. Congenital erythropoietic porphyria: characterization of murine models of the severe common (C73R/C73R) and later-onset genotypes. Mol Med. 2011; 17(7-8):748-56.
      View in: PubMed
    9. Hasanoglu A, Balwani M, Kasapkara CS, Ezgü FS, Okur I, Tümer L, Cakmak A, Nazarenko I, Yu C, Clavero S, Bishop DF, Desnick RJ. Harderoporphyria due to homozygosity for coproporphyrinogen oxidase missense mutation H327R. J Inherit Metab Dis. 2011 Feb; 34(1):225-31.
      View in: PubMed
    10. Clavero S, Bishop DF, Giger U, Haskins ME, Desnick RJ. Feline congenital erythropoietic porphyria: two homozygous UROS missense mutations cause the enzyme deficiency and porphyrin accumulation. Mol Med. 2010 Sep-Oct; 16(9-10):381-8.
      View in: PubMed
    11. Hare D, Tolmachev S, James A, Bishop D, Austin C, Fryer F, Doble P. Elemental bio-imaging of thorium, uranium, and plutonium in tissues from occupationally exposed former nuclear workers. Anal Chem. 2010 Apr 15; 82(8):3176-82.
      View in: PubMed
    12. Bishop DF, Schneider-Yin X, Clavero S, Yoo HW, Minder EI, Desnick RJ. Congenital erythropoietic porphyria: a novel uroporphyrinogen III synthase branchpoint mutation reveals underlying wild-type alternatively spliced transcripts. Blood. 2010 Feb 4; 115(5):1062-9.
      View in: PubMed
    13. Clavero S, Bishop DF, Haskins ME, Giger U, Kauppinen R, Desnick RJ. Feline acute intermittent porphyria: a phenocopy masquerading as an erythropoietic porphyria due to dominant and recessive hydroxymethylbilane synthase mutations. Hum Mol Genet. 2010 Feb 15; 19(4):584-96.
      View in: PubMed
    14. Yasuda M, Bishop DF, Fowkes M, Cheng SH, Gan L, Desnick RJ. AAV8-mediated gene therapy prevents induced biochemical attacks of acute intermittent porphyria and improves neuromotor function. Mol Ther. 2010 Jan; 18(1):17-22.
      View in: PubMed
    15. Scher W, Jing Y, Lu M, Bishop DF, Scher BM. Sequences of polycythemia-type Friend spleen focus-forming virus in clone-745-derived mouse erythroleukemia cells. Arch Virol. 2009; 154(5):895-8.
      View in: PubMed
    16. Cunha L, Kuti M, Bishop DF, Mezei M, Zeng L, Zhou MM, Desnick RJ. Human uroporphyrinogen III synthase: NMR-based mapping of the active site. Proteins. 2008 May 1; 71(2):855-73.
      View in: PubMed
    17. Yasuda M, Domaradzki ME, Armentano D, Cheng SH, Bishop DF, Desnick RJ. Acute intermittent porphyria: vector optimization for gene therapy. J Gene Med. 2007 Sep; 9(9):806-11.
      View in: PubMed
    18. Bishop DF, Johansson A, Phelps R, Shady AA, Ramirez MC, Yasuda M, Caro A, Desnick RJ. Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions. Am J Hum Genet. 2006 Apr; 78(4):645-58.
      View in: PubMed
    19. Chan P, Gonzalez-Maeso J, Ruf F, Bishop DF, Hof PR, Sealfon SC. Epsilon-sarcoglycan immunoreactivity and mRNA expression in mouse brain. J Comp Neurol. 2005 Jan 31; 482(1):50-73.
      View in: PubMed
    20. Solis C, Martinez-Bermejo A, Naidich TP, Kaufmann WE, Astrin KH, Bishop DF, Desnick RJ. Acute intermittent porphyria: studies of the severe homozygous dominant disease provides insights into the neurologic attacks in acute porphyrias. Arch Neurol. 2004 Nov; 61(11):1764-70.
      View in: PubMed
    21. Bekri S, May A, Cotter PD, Al-Sabah AI, Guo X, Masters GS, Bishop DF. A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia. Blood. 2003 Jul 15; 102(2):698-704.
      View in: PubMed
    22. Turner J, Nicholas H, Bishop D, Matthews JM, Crossley M. The LIM protein FHL3 binds basic Krüppel-like factor/Krüppel-like factor 3 and its co-repressor C-terminal-binding protein 2. J Biol Chem. 2003 Apr 11; 278(15):12786-95.
      View in: PubMed
    23. Cazzola M, May A, Bergamaschi G, Cerani P, Ferrillo S, Bishop DF. Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation. Blood. 2002 Dec 1; 100(12):4236-8.
      View in: PubMed
    24. Shady AA, Colby BR, Cunha LF, Astrin KH, Bishop DF, Desnick RJ. Congenital erythropoietic porphyria: identification and expression of eight novel mutations in the uroporphyrinogen III synthase gene. Br J Haematol. 2002 Jun; 117(4):980-7.
      View in: PubMed
    25. Su X, Wallenstein S, Bishop D. Nonoverlapping clusters: approximate distribution and application to molecular biology. Biometrics. 2001 Jun; 57(2):420-6.
      View in: PubMed
    26. Solis C, Aizencang GI, Astrin KH, Bishop DF, Desnick RJ. Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria. J Clin Invest. 2001 Mar; 107(6):753-62.
      View in: PubMed
    27. Cazzola M, May A, Bergamaschi G, Cerani P, Rosti V, Bishop DF. Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females. Blood. 2000 Dec 15; 96(13):4363-5.
      View in: PubMed
    28. Aizencang G, Solis C, Bishop DF, Warner C, Desnick RJ. Human uroporphyrinogen-III synthase: genomic organization, alternative promoters, and erythroid-specific expression. Genomics. 2000 Dec 1; 70(2):223-31.
      View in: PubMed
    29. Bekri S, Kispal G, Lange H, Fitzsimons E, Tolmie J, Lill R, Bishop DF. Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation. Blood. 2000 Nov 1; 96(9):3256-64.
      View in: PubMed
    30. Aizencang GI, Bishop DF, Forrest D, Astrin KH, Desnick RJ. Uroporphyrinogen III synthase. An alternative promoter controls erythroid-specific expression in the murine gene. J Biol Chem. 2000 Jan 28; 275(4):2295-304.
      View in: PubMed
    31. Cotter PD, May A, Li L, Al-Sabah AI, Fitzsimons EJ, Cazzola M, Bishop DF. Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis. Blood. 1999 Mar 1; 93(5):1757-69.
      View in: PubMed
    32. May A, Bishop DF. The molecular biology and pyridoxine responsiveness of X-linked sideroblastic anaemia. Haematologica. 1998 Jan; 83(1):56-70.
      View in: PubMed
    33. Fitzmaurice TF, Desnick RJ, Bishop DF. Human alpha-galactosidase A: high plasma activity expressed by the -30G-->A allele. J Inherit Metab Dis. 1997 Sep; 20(5):643-57.
      View in: PubMed
    34. Gotlib RW, Bishop DF, Wang AM, Zeidner KM, Ioannou YA, Adler DA, Disteche CM, Desnick RJ. The entire genomic sequence and cDNA expression of mouse alpha-galactosidase A. Biochem Mol Med. 1996 Apr; 57(2):139-48.
      View in: PubMed
    35. Cotter PD, May A, Fitzsimons EJ, Houston T, Woodcock BE, al-Sabah AI, Wong L, Bishop DF. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts. J Clin Invest. 1995 Oct; 96(4):2090-6.
      View in: PubMed
    36. Bottomley SS, May BK, Cox TC, Cotter PD, Bishop DF. Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia. J Bioenerg Biomembr. 1995 Apr; 27(2):161-8.
      View in: PubMed
    37. Cotter PD, Drabkin HA, Varkony T, Smith DI, Bishop DF. Assignment of the human housekeeping delta-aminolevulinate synthase gene (ALAS1) to chromosome band 3p21.1 by PCR analysis of somatic cell hybrids. Cytogenet Cell Genet. 1995; 69(3-4):207-8.
      View in: PubMed
    38. Cotter PD, Rucknagel DL, Bishop DF. X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley. Blood. 1994 Dec 1; 84(11):3915-24.
      View in: PubMed
    39. Chapman VM, Keitz BT, Bishop DF. Genetic linkage of the erythroid-specific delta-aminolevulinate synthase gene (Alas2) to the distal region of the mouse X chromosome. Mamm Genome. 1994 Nov; 5(11):741.
      View in: PubMed
    40. Jardine PE, Cotter PD, Johnson SA, Fitzsimons EJ, Tyfield L, Lunt PW, Bishop DF. Pyridoxine-refractory congenital sideroblastic anaemia with evidence for autosomal inheritance: exclusion of linkage to ALAS2 at Xp11.21 by polymorphism analysis. J Med Genet. 1994 Mar; 31(3):213-8.
      View in: PubMed
    41. Ioannou YA, Bishop DF, Desnick RJ. Overexpression of human alpha-galactosidase A results in its intracellular aggregation, crystallization in lysosomes, and selective secretion. J Cell Biol. 1992 Dec; 119(5):1137-50.
      View in: PubMed
    42. Cotter PD, Willard HF, Gorski JL, Bishop DF. Assignment of human erythroid delta-aminolevulinate synthase (ALAS2) to a distal subregion of band Xp11.21 by PCR analysis of somatic cell hybrids containing X; autosome translocations. Genomics. 1992 May; 13(1):211-2.
      View in: PubMed
    43. Cotter PD, Baumann M, Bishop DF. Enzymatic defect in "X-linked" sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency. Proc Natl Acad Sci U S A. 1992 May 1; 89(9):4028-32.
      View in: PubMed
    44. Sakuraba H, Eng CM, Desnick RJ, Bishop DF. Invariant exon skipping in the human alpha-galactosidase A pre-mRNA: Ag+1 to t substitution in a 5'-splice site causing Fabry disease. Genomics. 1992 Apr; 12(4):643-50.
      View in: PubMed
    45. von Scheidt W, Eng CM, Fitzmaurice TF, Erdmann E, Hübner G, Olsen EG, Christomanou H, Kandolf R, Bishop DF, Desnick RJ. An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med. 1991 Feb 7; 324(6):395-9.
      View in: PubMed
    46. Wang AM, Bishop DF, Desnick RJ. Human alpha-N-acetylgalactosaminidase-molecular cloning, nucleotide sequence, and expression of a full-length cDNA. Homology with human alpha-galactosidase A suggests evolution from a common ancestral gene. J Biol Chem. 1990 Dec 15; 265(35):21859-66.
      View in: PubMed
    47. Bishop DF. Two different genes encode delta-aminolevulinate synthase in humans: nucleotide sequences of cDNAs for the housekeeping and erythroid genes. Nucleic Acids Res. 1990 Dec 11; 18(23):7187-8.
      View in: PubMed
    48. Sakuraba H, Oshima A, Fukuhara Y, Shimmoto M, Nagao Y, Bishop DF, Desnick RJ, Suzuki Y. Identification of point mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease. Am J Hum Genet. 1990 Nov; 47(5):784-9.
      View in: PubMed
    49. Kornreich R, Bishop DF, Desnick RJ. Alpha-galactosidase A gene rearrangements causing Fabry disease. Identification of short direct repeats at breakpoints in an Alu-rich gene. J Biol Chem. 1990 Jun 5; 265(16):9319-26.
      View in: PubMed
    50. Bishop DF, Henderson AS, Astrin KH. Human delta-aminolevulinate synthase: assignment of the housekeeping gene to 3p21 and the erythroid-specific gene to the X chromosome. Genomics. 1990 Jun; 7(2):207-14.
      View in: PubMed
    51. Sakuraba H, Bishop DF, Suzuki T, Suzuki Y, Desnick RJ. [Partial deletion of alpha-galactosidase A gene in a Japanese mutant of Fabry disease]. No To Hattatsu. 1990 May; 22(3):247-52.
      View in: PubMed
    52. Schindler D, Bishop DF, Wolfe DE, Wang AM, Egge H, Lemieux RU, Desnick RJ. Neuroaxonal dystrophy due to lysosomal alpha-N-acetylgalactosaminidase deficiency. N Engl J Med. 1989 Jun 29; 320(26):1735-40.
      View in: PubMed
    53. Kornreich R, Desnick RJ, Bishop DF. Nucleotide sequence of the human alpha-galactosidase A gene. Nucleic Acids Res. 1989 Apr 25; 17(8):3301-2.
      View in: PubMed
    54. Bernstein HS, Bishop DF, Astrin KH, Kornreich R, Eng CM, Sakuraba H, Desnick RJ. Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene. J Clin Invest. 1989 Apr; 83(4):1390-9.
      View in: PubMed
    55. Desnick RJ, Astrin KH, Bishop DF. Fabry disease: molecular genetics of the inherited nephropathy. Adv Nephrol Necker Hosp. 1989; 18:113-27.
      View in: PubMed
    56. Kornreich R, Bishop DF, Desnick RJ. The gene encoding alpha-galactosidase A and gene rearrangements causing Fabry disease. Trans Assoc Am Physicians. 1989; 102:30-43.
      View in: PubMed
    57. Tsai SF, Bishop DF, Desnick RJ. Human uroporphyrinogen III synthase: molecular cloning, nucleotide sequence, and expression of a full-length cDNA. Proc Natl Acad Sci U S A. 1988 Oct; 85(19):7049-53.
      View in: PubMed
    58. Bishop DF, Kornreich R, Desnick RJ. Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3' untranslated region. Proc Natl Acad Sci U S A. 1988 Jun; 85(11):3903-7.
      View in: PubMed
    59. Bonkovsky HL, Healey JF, Lincoln B, Bacon BR, Bishop DF, Elder GH. Hepatic heme synthesis in a new model of experimental hemochromatosis: studies in rats fed finely divided elemental iron. Hepatology. 1987 Nov-Dec; 7(6):1195-203.
      View in: PubMed
    60. Tsai SF, Bishop DF, Desnick RJ. Coupled-enzyme and direct assays for uroporphyrinogen III synthase activity in human erythrocytes and cultured lymphoblasts. Enzymatic diagnosis of heterozygotes and homozygotes with congenital erythropoietic porphyria. Anal Biochem. 1987 Oct; 166(1):120-33.
      View in: PubMed
    61. Potluri VR, Astrin KH, Wetmur JG, Bishop DF, Desnick RJ. Human delta-aminolevulinate dehydratase: chromosomal localization to 9q34 by in situ hybridization. Hum Genet. 1987 Jul; 76(3):236-9.
      View in: PubMed
    62. Lemansky P, Bishop DF, Desnick RJ, Hasilik A, von Figura K. Synthesis and processing of alpha-galactosidase A in human fibroblasts. Evidence for different mutations in Fabry disease. J Biol Chem. 1987 Feb 15; 262(5):2062-5.
      View in: PubMed
    63. Tsai SF, Bishop DF, Desnick RJ. Purification and properties of uroporphyrinogen III synthase from human erythrocytes. J Biol Chem. 1987 Jan 25; 262(3):1268-73.
      View in: PubMed
    64. Astrin KH, Bishop DF, Wetmur JG, Kaul B, Davidow B, Desnick RJ. delta-Aminolevulinic acid dehydratase isozymes and lead toxicity. Ann N Y Acad Sci. 1987; 514:23-9.
      View in: PubMed
    65. Desnick RJ, Bernstein HS, Astrin KH, Bishop DF. Fabry disease: molecular diagnosis of hemizygotes and heterozygotes. Enzyme. 1987; 38(1-4):54-64.
      View in: PubMed
    66. Wetmur JG, Bishop DF, Cantelmo C, Desnick RJ. Human delta-aminolevulinate dehydratase: nucleotide sequence of a full-length cDNA clone. Proc Natl Acad Sci U S A. 1986 Oct; 83(20):7703-7.
      View in: PubMed
    67. Bishop DF, Calhoun DH, Bernstein HS, Hantzopoulos P, Quinn M, Desnick RJ. Human alpha-galactosidase A: nucleotide sequence of a cDNA clone encoding the mature enzyme. Proc Natl Acad Sci U S A. 1986 Jul; 83(13):4859-63.
      View in: PubMed
    68. Bishop DF, Desnick RJ. Porphobilinogen synthase: a specific and sensitive coupled-enzyme assay. Methods Enzymol. 1986; 123:339-45.
      View in: PubMed
    69. Wetmur JG, Bishop DF, Ostasiewicz L, Desnick RJ. Molecular cloning of a cDNA for human delta-aminolevulinate dehydratase. Gene. 1986; 43(1-2):123-30.
      View in: PubMed
    70. Calhoun DH, Bishop DF, Bernstein HS, Quinn M, Hantzopoulos P, Desnick RJ. Fabry disease: isolation of a cDNA clone encoding human alpha-galactosidase A. Proc Natl Acad Sci U S A. 1985 Nov; 82(21):7364-8.
      View in: PubMed
    71. Mohandas T, Sparkes RS, Bishop DF, Desnick RJ, Shapiro LJ. Frequency of reactivation and variability in expression of X-linked enzyme loci. Am J Hum Genet. 1984 Jul; 36(4):916-25.
      View in: PubMed
    72. Bishop DF, McBride L, Desnick RJ. Fluorometric coupled-enzyme assay for delta-aminolevulinate synthase. Enzyme. 1982; 28(2-3):94-108.
      View in: PubMed
    73. Bishop DF, Desnick RJ. Assays of the heme biosynthetic enzymes. Preface. Enzyme. 1982; 28(2-3):91-3.
      View in: PubMed
    74. Bishop DF, Devey KR, McBride L, Desnick RJ. Rapid determination of delta-aminolevulinate synthase activity by a specific fluorometric coupled enzyme assay. Anal Biochem. 1981 May 1; 113(1):68-78.
      View in: PubMed
    75. Faraggiana T, Churg J, Grishman E, Strauss L, Prado A, Bishop DF, Schuchman E, Desnick RJ. Light- and electron-microscopic histochemistry of Fabry's disease. Am J Pathol. 1981 May; 103(2):247-62.
      View in: PubMed
    76. Bishop DF, Desnick RJ. Affinity purification of alpha-galactosidase A from human spleen, placenta, and plasma with elimination of pyrogen contamination. Properties of the purified splenic enzyme compared to other forms. J Biol Chem. 1981 Feb 10; 256(3):1307-16.
      View in: PubMed
    77. Bishop DF, Kitchen H, Wood WA. Evidence for erythroid and nonerythroid forms of delta-aminolevulinate synthetase. Arch Biochem Biophys. 1981 Feb; 206(2):380-91.
      View in: PubMed
    78. Bishop DF, Dean KJ, Sweeley CC, Desnick RJ. Purification and characterization of human alpha-galactosidase isozymes: comparison of tissue and plasma forms and evaluation of purification methods. Birth Defects Orig Artic Ser. 1980; 16(1):17-32.
      View in: PubMed
    79. Desnick RJ, Dean KJ, Grabowski GA, Bishop DF, Sweeley CC. Enzyme therapy XVII: metabolic and immunologic evaluation of alpha- galactosidase A replacement in Fabry disease. Birth Defects Orig Artic Ser. 1980; 16(1):393-413.
      View in: PubMed
    80. Desnick RJ, Dean KJ, Grabowski G, Bishop DF, Sweeley CC. Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes. Proc Natl Acad Sci U S A. 1979 Oct; 76(10):5326-30.
      View in: PubMed
    81. Bishop DF, Sweeley CC. Plasma alpha-galactosidase A:properties and comparisons with tissue alpha-galactosidases. Biochim Biophys Acta. 1978 Aug 7; 525(2):399-409.
      View in: PubMed
    82. Bishop DF, Wampler DE, Sgouris JT, Bonefeld RJ, Anderson DK, Hawley MC, Sweeley CC. Pilot scale purification of alpha-galactosidase A from Cohn fraction IV-1 of human plasma. Biochim Biophys Acta. 1978 May 11; 524(1):109-20.
      View in: PubMed
    83. Bishop DF, Wood WA. An assay for delta-aminolevulinic acid synthetase based on a specific, semiautomatic determination of picomole quantities of delta-[14C]aminolevulinate. Anal Biochem. 1977 Jun; 80(2):466-82.
      View in: PubMed
    Bishop's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067